Physician profile
Scott A Wingerter
NPI 1356549075
$4,518.85
in general payments reported to CMS, 2019-2025
9 companies · $1,375 in 2025
The $1,375 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $577 · 2020: $384 · 2021: $516 · 2022: $445 · 2023: $615 · 2024: $607 · 2025: $1,375.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,597 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,596.51 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,724.00 | 2019-2025 | Mako, Accolade, Actishield |
| Applied Medical Resources Corporation | $1,000.00 | 2025 | |
| Horizon Therapeutics Plc | $436.62 | 2019-2021 | |
| Becton, Dickinson and Company | $163.84 | 2022 | |
| Linvatec Corporation | $65.15 | 2023 | Hall Power |
| Medtronic USA, INC. | $49.84 | 2019 | |
| Zimmer Biomet Holdings, INC. | $45.38 | 2019 | |
| Bioventus LLC | $17.98 | 2019 | |
| Orthogenrx INC. | $16.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Wingerter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.